The Children’s Tumor Foundation NF + SWN Diagnosis App is designed to support healthcare providers as a useful tool for diagnosing patients who may have neurofibromatosis (NF) or schwannomatosis or a related disroder. With a special focus on the 2021 and 2022 updates to the diagnostic criteria, the app compiles the most relevant, evidence-based clinical guidelines from multiple sources into a single tool and places them at the clinician’s finger tips.
This free app was created by the Children’s Tumor Foundation as a tool for medical professionals, clinicians, genetic counselors, medical students, and general practitioners.
About Children’s Tumor Foundation
Founded in 1978, the Children’s Tumor Foundation (CTF) began as the first grassroots organization solely dedicated to finding treatments for NF. Today, CTF is a highly recognized global nonprofit foundation, the leading force in the fight to end NF, and a model for other innovative research endeavors.
Our Mission: Drive research, expand knowledge, and advance care for the NF community.
Our Vision: End NF.
Only a medical professional can confirm a diagnosis of NF1, Legius Syndrome, or any type of schwannomatosis (including NF2-related schwannomatosis, formerly called NF2) This mobile app is a tool and not a replacement for diagnostic assessment and medical management from a healthcare provider.
This free app was created by the Children’s Tumor Foundation as a tool for medical professionals, clinicians, genetic counselors, medical students, and general practitioners.
About Children’s Tumor Foundation
Founded in 1978, the Children’s Tumor Foundation (CTF) began as the first grassroots organization solely dedicated to finding treatments for NF. Today, CTF is a highly recognized global nonprofit foundation, the leading force in the fight to end NF, and a model for other innovative research endeavors.
Our Mission: Drive research, expand knowledge, and advance care for the NF community.
Our Vision: End NF.
Only a medical professional can confirm a diagnosis of NF1, Legius Syndrome, or any type of schwannomatosis (including NF2-related schwannomatosis, formerly called NF2) This mobile app is a tool and not a replacement for diagnostic assessment and medical management from a healthcare provider.
Show More
